Dec 13, 2025 15:15
BIOA - BioAge Labs, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 8.65 0.07 (0.81%) | --- | -0.06 (-0.68%) | -0.16 (-1.8%) | 0.0 (0.0%) | 0.13 (1.51%) | 0.0 (0.0%) | 0.05 (0.58%) |
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.6
- Diluted EPS:
- -0.6
- Basic P/E:
- -14.5333
- Diluted P/E:
- -14.5333
- RSI(14) 1m:
- 35.46
- VWAP:
- 8.73
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Nov 18, 2025 18:02
Nov 07, 2025 14:00
Oct 26, 2025 22:33
Aug 15, 2025 13:00
Aug 07, 2025 03:14
Mar 08, 2025 12:34
Mar 05, 2025 17:00
Mar 03, 2025 21:00
Mar 02, 2025 18:14